Dr. Gordon DeWald, professor emeritus in laboratory medicine and laboratory genetics at Mayo Clinic, provides an overview of his study on the use of fluorescence in situ hybridization (FISH) to visualize genetic abnormalities characteristic of pancreatic cancer. Article available at: http://tinyurl.com/cwbzue8